Loading…
Loading…
See exactly how RXD's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RXD and 80,000+ other tickers.
ProShares UltraShort Health Care is engineered to provide daily financial performance, prior to any costs or charges, that reflects two times the inverse (-2x) of the S&P Health Care Select SectorSM Index's daily fluctuations.
ProShares UltraShort Health Care (NYSEARCA:RXD - Get Free Report) was the recipient of a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 9,205 shares, a growth of 25.1% from the December 15th total of 7,358 shares. Approximately 7.7% of the shares of the company
Wall Street saw a strong start to August but the rally fizzled in the last couple of weeks, driven by renewed aggressive Fed rate hike speculation.
We are bearish on all American bear market ETFs. Measuring the purchase levels of short ETFs replaces the old, odd lot and total short selling indicators so popular in the 1960s, 70s and 80s.
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.